148 related articles for article (PubMed ID: 36479633)
1. DEPDC1 as a crucial factor in the progression of human osteosarcoma.
Shen L; Li H; Liu R; Zhou C; Bretches M; Gong X; Lu L; Zhang Y; Zhao K; Ning B; Yang SY; Zhang A
Cancer Med; 2023 Mar; 12(5):5798-5808. PubMed ID: 36479633
[TBL] [Abstract][Full Text] [Related]
2. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
Qu D; Cui F; Lu D; Yang Y; Xu Y
Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
[TBL] [Abstract][Full Text] [Related]
3. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
Shen J; Xi M
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
[TBL] [Abstract][Full Text] [Related]
4. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
[No Abstract] [Full Text] [Related]
5. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.
Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189746
[TBL] [Abstract][Full Text] [Related]
6. DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.
Huang L; Chen K; Cai ZP; Chen FC; Shen HY; Zhao WH; Yang SJ; Chen XB; Tang GX; Lin X
Biochem Biophys Res Commun; 2017 Aug; 490(3):707-712. PubMed ID: 28634077
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA
Xu W; Wang J; Xu J; Li S; Zhang R; Shen C; Xie M; Zheng B; Gu M
J Int Med Res; 2022 Apr; 50(4):3000605221093135. PubMed ID: 35466755
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
[TBL] [Abstract][Full Text] [Related]
9. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
10. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
[TBL] [Abstract][Full Text] [Related]
11. Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1.
Sharen G; Li X; Sun J; Zhang L; Xi W; Zhao X; Han F; Jia L; A R; Cheng H; Hou M
J Transl Med; 2022 Oct; 20(1):493. PubMed ID: 36309731
[TBL] [Abstract][Full Text] [Related]
12. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
Yang M; Zhang H; Gao S; Huang W
J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
[TBL] [Abstract][Full Text] [Related]
13. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
[TBL] [Abstract][Full Text] [Related]
14. DEPDC1 upregulation promotes cell proliferation and predicts poor prognosis in patients with gastric cancer.
Gong Z; Chu H; Chen J; Jiang L; Gong B; Zhu P; Zhang C; Wang Z; Zhang W; Wang J; Li C; Zhao H
Cancer Biomark; 2021; 30(3):299-307. PubMed ID: 33361586
[TBL] [Abstract][Full Text] [Related]
15. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
Shen X; Han J
J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
[TBL] [Abstract][Full Text] [Related]
17. DEPDC1 up-regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells.
Wang W; Li A; Han X; Wang Q; Guo J; Wu Y; Wang C; Huang G
J Cell Mol Med; 2020 Nov; 24(22):13303-13313. PubMed ID: 33021072
[TBL] [Abstract][Full Text] [Related]
18. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
[TBL] [Abstract][Full Text] [Related]
19. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
20. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
